Cantourage Group SE

New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets

Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth

The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024

Medizinisches Cannabis boomt: Cantourage Group SE verzeichnet Rekordquartal in Q3 2024

Cantourage Group SE verzeichnet im Zeitraum Januar bis August 2024 höhere Umsatzerlöse als im Gesamtjahr 2023

Cantourage Group SE verzeichnet im Zeitraum Januar bis August 2024 höhere Umsatzerlöse als im Gesamtjahr 2023

Cantourage Group SE shows strong business performance and high growth momentum in the first half of 2024

Cantourage Group SE: Strong growth continues – another monthly sales record in June 2024

Cantourage Group SE records highest monthly revenue in company history in May 2024

Cantourage Group SE records strong growth in revenue and EBITDA in the break-even range in 2023. Strong growth since the partial legalisation of cannabis came into force.

Ad-hoc: Cantourage Group SE records strong growth in 2024 since the partial legalisation of cannabis came into force

Cantourage Group SE – Gründer und Frühphaseinvestoren haben Aktien zur Erhöhung des Freefloats abgegeben, um den Einstieg für Investoren zu vereinfachen

Cantourage Group SE records significant revenue growth in the first nine months of 2023 and confirms full-year forecast

Cantourage Group SE: NuWays confirms ‘Buy’ recommendation

Cantourage Group SE launches a range of high-THC medicinal cannabis flowers in Switzerland together with Astrasana

Montega AG includes Cantourage Group SE in its coverage with ‘Buy’

Cantourage Group SE: Cantourage shortlisted for European Small and Mid-Cap Awards 2023

Telecan°: Germany’s largest medical cannabis company launches online platform for cannabis on prescription 

Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly resource-saving aeroponic cultivation technology

Cantourage Group SE continues profitable growth course in first half of 2023

Cantourage Group SE gibt Prognose für das Geschäftsjahr 2023 bekannt und prüft weitere Finanzierungsoptionen einschließlich Kapitalmarktfinanzierungen zu Unterstützung weiteren Wachstums

Cantourage Group SE welcomes draft bill of the Federal Ministry of Health on the new Cannabis Act and an amendment to the Medical Cannabis Act

Cantourage Group SE announces partnership with Canadian grower Costa Canna

Cantourage Group SE starts cooperation with a leading pharmaceutical wholesaler in Austria to supply the market with THC

Cantourage Group SE sets corporate record: four new cultivation partners within a month

Canadian cannabis producer Green Karat enters German craft cannabis market in partnership with Cantourage

Cantourage Group SE: Research update confirms positive development of Cantourage shares and changes valuation recommendation to “Buy”

Cantourage Group SE: Established cannabis brand from Canada: Cantourage brings Breathing Green to German pharmacies

Cantourage Group SE generates profit in first quarter of 2023

Cantourage Group SE exportiert erstmals Dronabinol und CBD nach Kroatien